Ares Commercial Real Estate heads into its third-quarter report with a striking disconnect. Last quarter management described a bigger, cleaner and less office-heavy loan book, yet the stock has since fallen nearly 27% while the S&P 500 edged higher. At $3.42, shares trade well below the 200-day moving average of $4.68 and only modestly above the post-earnings low of $3.16. The quarterly 15-cent dividend now implies a yield of roughly 17.5%, a level that signals the market is questioning whether the payout can survive, not celebrating it.
The Street is looking for earnings of $0.11 a share, flat with the prior quarter and up 37.5% from the $0.08 earned a year ago. The year-over-year gain mostly reflects a weak comparison and a portfolio that has grown sharply, with loans held for investment reaching $1.8 billion last quarter, up about $484 million from a year earlier. Consensus revenue of $28.6 million is roughly double both the prior quarter and the year-ago figure, a jump that likely reflects a different reporting basis rather than a sudden doubling of earning power, so the EPS figure is the more meaningful yardstick. The awkward arithmetic is that even last quarter's clean distributable result of $0.12 fell short of the 15-cent dividend, and an $0.11 quarter would widen that gap.
Management's path to closing it runs through problem loans, not new originations. The company reiterated a route to a 9% to 10% return on equity once its risk-rated 4 and 5 loans are resolved, and more than $150 million of non-accrual carrying value is still dragging on income. The Chicago office loan is the clearest test. Its sale process was extended again, to October 2026, which means this report should reveal whether a deal closed, slipped once more, or required a price that dents book value. Progress on the substantially completed Brooklyn condo project, where pre-sales were underway, and the North Carolina office REO, which drew strong interest when marketed, would offer further proof that capital trapped in nonearning assets can be recycled into higher-yielding loans.
Credit migration is the other swing factor. Last quarter marked the third straight period with no loans rated 1 through 3 sliding to 4 or 5, and reserves barely moved. A repeat would support the stabilization story. A fresh downgrade, especially in industrial after the $13 million California subordinate loan was cut to a 5 ahead of its January 2027 maturity, would suggest weakness is spreading beyond office. Book value deserves equal scrutiny; it has slipped from $9.47 to $8.82 over four quarters, and another decline would undercut the argument that losses are behind the company.
Capital deployment matters too. Available capital fell to $106 million as originations outpaced repayments, which had been slowing. With the stock deep below book, use of the newly reauthorized $50 million buyback would be a telling signal of management's confidence and could be accretive, though it competes with lending for limited dry powder. Commentary on the held-for-sale strategy, which generated incremental fees on a California retail loan, would indicate whether that earnings lever is repeatable. The COO transition and management's cautious view on rates and inflation add background uncertainty.
Sentiment has swung from modestly bearish before the last report to modestly bullish now, suggesting some investors see the selloff as overdone. That leaves room for relief if the numbers cooperate. Ultimately, though, the quarter will be judged on one question: whether Ares can show tangible resolution of its nonaccrual loans, starting with Chicago, quickly enough to make the 15-cent dividend look earned rather than borrowed from book value.